Impact ledger
Oncolytics Biotech Inc. (ONCY): the developments shaping its investment case
Follow the evidence affecting Oncolytics Biotech Inc.. Review the key developments below. Continue in Market Ontology to test your assumptions, examine related opportunities, and save the investment case you want to track.
Research Oncolytics Biotech Inc. · $399/mo
Test assumptions, examine opportunities, and save your research.
Material developments
2026-09-29 · 3 reports
Oncolytics Biotech Inc. Announces Publication of Pelareorep Data in Liver Cancer
Channel: Direct positive clinical data publication for lead asset, potentially increasing investor confidence and market visibility.
Bullish· 1-3m
Event impact log
3 events mapped to ONCY since 2026-09-29. Evidence through 2026-09-29.
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-09-29 | Oncolytics Biotech Inc. Announces Publication of Pelareorep Data in Liver Cancer | Direct positive clinical data publication for lead asset, potentially increasing investor confidence and market visibility. | Bullish | 1-3m | 0.70 |
| 2026-09-29 | Oncolytics Biotech Announces Publication of Pelareorep Data in Liver Cancer | Positive clinical data publication enhancing drug candidate's profile and market perception, potentially attracting partnerships or investment. | Bullish | 1-3m | 0.80 |
| 2026-09-29 | Oncolytics Biotech Inc Announces Publication of Pelareorep Liver Cancer Data | Direct positive clinical data for lead therapeutic candidate, increasing probability of future regulatory success and commercialization. | Bullish | 1-3m | 0.80 |
Continue this research
Build your Oncolytics Biotech Inc. investment case. Continue from the evidence above, change the assumptions the developments move, and save the work to revisit as the case develops.
This ledger is regenerated from Market Ontology's public event pipeline. View the ONCY entity page →